£107.98

Springer The Epothilones: An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic: 90 (Fortschritte der Chemie organischer Naturstoffe Progress in the Chemistry of Organic Natural Products, 90)

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 90 days • 90 data points

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 11 February 2026 05 March 2026 27 March 2026 18 April 2026 11 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
86 days 4 days · current 0 22 43 65 86 £107 £108 Days at Price

Price Analysis

Most common price: £107 (86 days, 95.6%)

Price range: £107 - £108

Price levels: 2 different prices over 90 days

Description

Epothilones have received unusual attention over the past ten years. They are novel antitumor drugs which very much like their predecessor paclitaxel (Taxol) act via microtubule stabilization. In comparison to paclitaxel and a number of alternative drugs with a similar mode of bioaction (e.g. laulimalide, eleutherobin, peluroside, discodermolide) the epothilones have significant advantages, above all very high activity in the nanomolar range and low susceptibility towards multidrug resistance. Epothilone B and several derivatives thereof are in phase I-III clinical trials; one of them (ixabepilone, BMS) is already on the market, others are supposed to appear on the market in the near future. All naturally occurring epothilones have been isolated from Sorangium cellulosum; their antitumor action is traced back to the stabilization of microtubules. In consequence, the formation of the mitototic spindle is prohibited and the cell undergoes apoptosis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
19 October 2010
Listed Since
22 November 2010

Barcode

No barcode data available

Similar Products You Might Like

Apoptosome: An up-and-coming therapeutical tool
76% match

Apoptosome: An up-and-coming therapeutical tool

Springer

£110.05 11 May 2026
Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research
76% match

Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research

Springer

£113.76 11 May 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
74% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.58 11 May 2026
Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer
74% match

Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer

Springer

£145.38 11 May 2026
Cell Signaling & Molecular Targets in Cancer
74% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Retinoids in Oncology (ESO Monographs)
73% match

Retinoids in Oncology (ESO Monographs)

Springer

£113.93 04 May 2026
Application of Apoptosis to Cancer Treatment
73% match

Application of Apoptosis to Cancer Treatment

Springer

£109.61 11 May 2026
DNA Methylation, Epigenetics and Metastasis: 7 (Cancer Metastasis - Biology and Treatment, 7)
73% match

DNA Methylation, Epigenetics and Metastasis: 7 (Cancer Metastasis - Biology and Treatment, 7)

Springer

£149.38 11 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
73% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 11 May 2026
Bioactive Essential Oils and Cancer
73% match

Bioactive Essential Oils and Cancer

Springer

£107.98 11 May 2026
Application of Apoptosis to Cancer Treatment
73% match

Application of Apoptosis to Cancer Treatment

Springer

£94.37 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
73% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
73% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 11 May 2026
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
72% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 11 May 2026
Protein Tyrosine Phosphatases in Cancer
72% match

Protein Tyrosine Phosphatases in Cancer

Springer

£113.18 04 May 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
72% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£123.38 11 May 2026
Quantum Chemistry Methods for Oncological Drugs
72% match

Quantum Chemistry Methods for Oncological Drugs

Elsevier

£133.05 04 May 2026
72% match

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice

Academic Press

£137.99 11 May 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
72% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 11 May 2026
Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer: 99 (Nato ASI Subseries H:, 99)
72% match

Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer: 99 (Nato ASI Subseries H:, 99)

Springer

£109.61 11 May 2026
72% match

Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies

Academic Press

£137.99 11 May 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
72% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£83.97 11 May 2026
Cell Signaling & Molecular Targets in Cancer
72% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
72% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026